Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 20812330)

1.

Short pediatric Crohn's disease activity index for quality improvement and observational research.

Kappelman MD, Crandall WV, Colletti RB, Goudie A, Leibowitz IH, Duffy L, Milov DE, Kim SC, Schoen BT, Patel AS, Grunow J, Larry E, Fairbrother G, Margolis P.

Inflamm Bowel Dis. 2011 Jan;17(1):112-7. doi: 10.1002/ibd.21452. Epub 2010 Sep 1.

2.

Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions.

Turner D, Griffiths AM, Walters TD, Seah T, Markowitz J, Pfefferkorn M, Keljo D, Waxman J, Otley A, LeLeiko NS, Mack D, Hyams J, Levine A.

Inflamm Bowel Dis. 2012 Jan;18(1):55-62. doi: 10.1002/ibd.21649. Epub 2011 Feb 23.

PMID:
21351206
3.

Is an abbreviated Pediatric Crohn's Disease Activity Index better than the original?

Shepanski MA, Markowitz JE, Mamula P, Hurd LB, Baldassano RN.

J Pediatr Gastroenterol Nutr. 2004 Jul;39(1):68-72.

PMID:
15187784
4.

Pediatric Crohn Disease Activity Index: responsive to short-term change.

Kundhal PS, Critch JN, Zachos M, Otley AR, Stephens D, Griffiths AM.

J Pediatr Gastroenterol Nutr. 2003 Jan;36(1):83-9.

PMID:
12500001
5.

Development and validation of a pediatric Crohn's disease activity index.

Hyams JS, Ferry GD, Mandel FS, Gryboski JD, Kibort PM, Kirschner BS, Griffiths AM, Katz AJ, Grand RJ, Boyle JT, et al.

J Pediatr Gastroenterol Nutr. 1991 May;12(4):439-47.

PMID:
1678008
6.

Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience.

Hyams J, Markowitz J, Otley A, Rosh J, Mack D, Bousvaros A, Kugathasan S, Pfefferkorn M, Tolia V, Evans J, Treem W, Wyllie R, Rothbaum R, del Rosario J, Katz A, Mezoff A, Oliva-Hemker M, Lerer T, Griffiths A; Pediatric Inflammatory Bowel Disease Collaborative Research Group.

J Pediatr Gastroenterol Nutr. 2005 Oct;41(4):416-21.

PMID:
16205508
7.

A critical assessment of items on the Pediatric Crohn's Disease Activity Index.

Loonen HJ, Griffiths AM, Merkus MP, Derkx HH.

J Pediatr Gastroenterol Nutr. 2003 Jan;36(1):90-5.

PMID:
12500002
8.

Assessing activity of pediatric Crohn's disease: which index to use?

Otley A, Loonen H, Parekh N, Corey M, Sherman PM, Griffiths AM.

Gastroenterology. 1999 Mar;116(3):527-31.

PMID:
10029610
9.

Appraisal of the pediatric Crohn's disease activity index on four prospectively collected datasets: recommended cutoff values and clinimetric properties.

Turner D, Griffiths AM, Walters TD, Seah T, Markowitz J, Pfefferkorn M, Keljo D, Otley A, Leleiko NS, Mack D, Hyams J, Levine A.

Am J Gastroenterol. 2010 Sep;105(9):2085-92. doi: 10.1038/ajg.2010.143. Epub 2010 Apr 6.

PMID:
20372111
10.

Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control.

van Rheenen PF.

Inflamm Bowel Dis. 2012 Nov;18(11):2018-25. doi: 10.1002/ibd.22896. Epub 2012 Jan 24.

PMID:
22275341
11.

Correlation of health-related quality of life in children with inflammatory bowel disease, their parents, and physician as measured by a visual analog scale.

Teitelbaum JE, Rajaraman RR, Jaeger J, Para S, Rakitt T.

J Pediatr Gastroenterol Nutr. 2013 Nov;57(5):594-7. doi: 10.1097/MPG.0b013e31829cf923.

PMID:
23752079
12.

Correlation of MMP-3 and MMP-9 with Crohn's disease activity in children.

Kofla-Dlubacz A, Matusiewicz M, Krzystek-Korpacka M, Iwanczak B.

Dig Dis Sci. 2012 Mar;57(3):706-12. doi: 10.1007/s10620-011-1936-z. Epub 2011 Oct 14.

13.

Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.

Sýkora J, Subrt I, Dìdek P, Siala K, Schwarz J, Machalová V, Varvarovská J, Pazdiora P, Pozler O, Stozický F.

J Pediatr Gastroenterol Nutr. 2006 May;42(5):479-87.

PMID:
16707968
14.

Development and assessment of a modified Pediatric Crohn Disease Activity Index.

Leach ST, Nahidi L, Tilakaratne S, Day AS, Lemberg DA.

J Pediatr Gastroenterol Nutr. 2010 Aug;51(2):232-6. doi: 10.1097/MPG.0b013e3181d13609.

PMID:
20479686
15.

Tolerance and efficacy of azathioprine in pediatric Crohn's disease.

Riello L, Talbotec C, Garnier-Lengliné H, Pigneur B, Svahn J, Canioni D, Goulet O, Schmitz J, Ruemmele FM.

Inflamm Bowel Dis. 2011 Oct;17(10):2138-43. doi: 10.1002/ibd.21612. Epub 2011 Jan 13.

PMID:
21910176
16.

Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.

Walters TD, Kim MO, Denson LA, Griffiths AM, Dubinsky M, Markowitz J, Baldassano R, Crandall W, Rosh J, Pfefferkorn M, Otley A, Heyman MB, LeLeiko N, Baker S, Guthery SL, Evans J, Ziring D, Kellermayer R, Stephens M, Mack D, Oliva-Hemker M, Patel AS, Kirschner B, Moulton D, Cohen S, Kim S, Liu C, Essers J, Kugathasan S, Hyams JS; PRO-KIIDS Research Group.

Gastroenterology. 2014 Feb;146(2):383-91. doi: 10.1053/j.gastro.2013.10.027. Epub 2013 Oct 23.

PMID:
24162032
17.

Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition.

Afzal NA, Van Der Zaag-Loonen HJ, Arnaud-Battandier F, Davies S, Murch S, Derkx B, Heuschkel R, Fell JM.

Aliment Pharmacol Ther. 2004 Jul 15;20(2):167-72.

18.
19.

Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's disease.

Baldassano R, Braegger CP, Escher JC, DeWoody K, Hendricks DF, Keenan GF, Winter HS.

Am J Gastroenterol. 2003 Apr;98(4):833-8.

PMID:
12738464
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk